A new HIV prevention drug, lenacapavir, has shown 100% protection in trials, offering hope for young women in Africa. Professor Linda-Gail Bekker believes it could be a game-changer in HIV prevention.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here